Optimizing fluoropyrimidine therapy: Real‐world impact of DPYD genotype‐based dosing on severe toxicity rates
Year: 2025
Type: article
Study design: Observational Study
DOI: 10.1002/bcp.70266
Authors: Anouk H. E. van Kan, Ankie M. Harmsze, Karin Herbschleb, Marcel P. H. van den Broek
Institutions: St. Antonius Ziekenhuis, Utrecht University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4413843709